Provectus makes Alfred Smith board member
This article was originally published in Scrip
Provectus Pharmaceuticals, a development stage oncology and dermatology biopharmaceutical company, has appointed Alfred Smith to its board of directors. Mr Smith is currently a senior advisor for the Marwood Group, Next Health and K2 Global Consulting. He was previously senior managing director at Bear Wagner Specialists.